- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Vanc Pharmaceuticals Responds to Canagen Compensation Claim
Vanc Pharmaceuticals responded to a demand letter released by Canagen Pharmaceuticals, in which they claim compensation of $510,000 from Vanc.
Vanc Pharmaceuticals (TSXV:VANC; OTCQB:NUVPF) responded to a demand letter released by Canagen Pharmaceuticals, in which they claim compensation of $510,000 from Vanc.
As quoted in the press release:
Vanc believes that the claims are wholly without merit, and intends to vigorously defend its position if an action is commenced. Vanc is issuing this news release only because Canagen took the extraordinary step of making public the delivery of its demand letter, and not because Vanc believes the allegations are material.
Vanc also announced today that it has delivered a formal demand to Mr. Mo Aziz and Canagen that they immediately and unqualifiedly publicly and prominently retract and apologize for their wrongful allegations and all other statements that disparage Vanc and its management. Vanc also demanded that no further disparagement of Vanc or its management take place.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.